Sfoglia per AUTORE
BALDONI A
Collezione AO Ordine Mauriziano
Items : 3
PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review. in International journal of molecular sciences / Int J Mol Sci. 2024 Jul 18;25(14):7887. doi: 10.3390/ijms25147887.
2024
AO Ordine Mauriziano
AO Ordine Mauriziano
Frezzini S; Tasca G; Borgato L; Sartor L; Ferrero A; Artioli G; Modena A; Baldoni A;
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. in Cancers / Cancers (Basel). 2023 Dec 20;16(1):41. doi: 10.3390/cancers16010041.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
Tuninetti V; Picardo E; Vertechy L; Bergamini A; Palaia I; Artioli G; Parisi A; Scandurra G; Scollo P; Baldoni A; Malaguti P; Cassani C; Zamagni C; Pisano C; Ricotti A; Marchetti C; Turinetto M; Scotto G; Scambia G; Pignata S; Valabrega G;
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer. in British journal of cancer / Br J Cancer. 2019 Oct;121(9):744-750. doi: 10.1038/s41416-019-0584-5. Epub 2019 Sep 20.
2019
AO Ordine Mauriziano
AO Ordine Mauriziano
Colombo N; Zaccarelli E; Baldoni A; Frezzini S; Scambia G; Palluzzi E; Tognon G; Lissoni AA; Rubino D; Ferrero A; Farina G; Negri E; Pesenti Gritti A; Galli F; Biagioli E; Rulli E; Poli D; Gerardi C; Torri V; Fossati R; D'Incalci M;